COVID-19 In-Vitro Diagnosis are designed to detect the SARS-CoV-2 virus.
At Koch Research, we researched their efficacy.
COVID-19 In-vitro Diagnosis Clinical Trials
Koch Research conducted diagnostic tests to find out if people have COVID-19 right now. These tests fall into three groups: molecular, antigen, and antibody tests. Molecular tests, like RT-PCR, look for the virus’s genes and are the best at finding COVID-19. Antigen tests look for proteins on the virus’s surface and give results faster, but they might not catch every case. Antibody tests check for antibodies your body made after fighting off COVID-19, showing you had it before, but they can’t tell if you’re still protected.
Current Status
Not Recruiting
Total Studies
05
Enrollment Process
Clinical trials are essential for advancing medical knowledge and improving patient care by testing the efficacy and safety of potential treatments before they are widely available to the public. Here’s what you can expect when considering enrollment.
Recruitment
Recruiting volunteers is the first step of an active clinical trial.
Phone Screening
You will undergo a phone screening to determine your eligibility.
Informed Consent
You must sign an ICF defining the purpose, procedure, potential risks & benefits, and your rights as participants.
